Abstract
ABSTRACT Drug-induced immune hemolytic anemia (DIIHA) is a rare condition that is often misdiagnosed or not diagnosed promptly, even at specialized medical facilities. The leading causes of DIIHA are antibiotics, particularly second and third-generation cephalosporins, and platinum-based chemotherapy. While identifying the responsible drug and discontinuing it typically resolves the issue, fatalities may still occur in cases of progressive immune-mediated hemolysis and underlying medical conditions. This case involves an 80-year-old man receiving injectable broad-spectrum antibiotics, including ceftriaxone, for pyogenic meningitis, who experienced severe hemolytic anemia that ultimately led to intracranial hemorrhage and death.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
